1- DiMario Jr, Francis J. Prospective Study of Children With Cyanotic and Pallid Breath-Holding Spells. Pediatrics. Feb 2001; 107:265-269
2- Mocan H, Yildiran A, Orhan F et al. Breath holding spells in 91 children and response to treatment with iron. Arch Dis Child. Sep 1999; 81(3): 261–262.
3- Moalla Y, Khemakhema K, Kossentini I et al. Comportement de l’enfant atteint de spasme du sanglot. Étude transversale. Neuropsychiatrie de l’enfance et de l’adolescence 59 (2011) 463–468
4- Sirjacq M. C'est un câlin que tu veux ? Revue française de psychosomatique. 2008 ; 33 : 135-145
5- Debray R. Hystérie et somatisation. Réflexions à propos d'un cas de spasmes du sanglot. Revue française de psychosomatique. 2004 ; 25 : 81-98
6- Lucet V. Le spasme du sanglot. 2012. Vidéo disponible sur le site Univadis
7- Azam M, Bhatti N, Shahab N. Piracetam in severe breath holding spells. Int J Psychiatry Med. 2008;38(2):195-201
8- Sawires H, Botrous O. Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells. Eur J Pediatr. 2012 Jul;171(7):1063-7
9- Donma MM. Clinical efficacy of piracetam in treatment of breath-holding spells. Pediatr Neurol. 1998 Jan;18(1):41-5
10- Yilmaz U, Doksoz O, Celik T, Akinci G, Mese T, Sevim Yilmaz T. The value of neurologic and cardiologic assessment in breath holding spells. Pak J Med Sci. 2014 Jan;30(1):59-64
11- Rathore G, Larsen P, Fernandez C, Parakh M. Diverse presentation of breath holding spells: two case reports with literature review. Case Rep Neurol Med. 2013;2013:603190
12- Abbaskhanian A, Ehteshami S, Sajjadi S, Rezai MS. Effects of piracetam on pediatric breath holding spells: a randomized double blind controlled trial. Iran J Child Neurol. 2012 Fall;6(4):9-15
13- Walsh M, Knilans TK, Anderson JB, Czosek RJ. Successful treatment of pallid breath-holding spells with fluoxetine. Pediatrics. 2012 Sep;130(3):e685-9
14- Ergul Y, Otar G, Nisli K, Dindar A. Permanent cardiac pacing in a 2.5 month-old infant with severe cyanotic breath-holding spells and prolonged asystole. Cardiol J. 2011;18(6):704-6
En 5 points
Obésité : suivi d’un patient sous aGLP-1
Cas clinique
La fasciite nécrosante
Mise au point
La périménopause
Mise au point
La sclérose en plaques